共 13 条
- [1] Heidenreich A(2013)EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer Eur. Urol. 65 467-479
- [2] Mohler JL(2012)Prostate cancer, version 3.2012: featured updates to the NCCN guidelines J. Natl Compr. Canc. Netw. 10 1081-1087
- [3] Rider JR(2013)Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study Eur. Urol. 63 88-96
- [4] Engel J(2010)Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer Eur. Urol. 57 754-761
- [5] Valastyan S(2011)Tumor metastasis: molecular insights and evolving paradigms Cell 147 275-292
- [6] Weinberg RA(2011)Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography Eur. Urol. 60 935-943
- [7] Rigatti P(2013)Comparative oncologic effectiveness of radical prostatectomy and radiotherapy in prostate cancer: An analysis of mortality outcomes in 34,515 patients treated with up to 15 years follow-up Eur. Urol. Suppl. 12 e912-305
- [8] Sooriakumaran P(2012)Complications and functional results of surgery for locally advanced prostate cancer Adv. Urol. 2012 706309-undefined
- [9] Joniau SG(2013)Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer Prostate 74 297-undefined
- [10] Van Baelen AA(undefined)undefined undefined undefined undefined-undefined